Pacific Biosciences Announces Fourth Quarter and Annual 2017 Financial Results

Pacific Biosciences of California (NASDAQ:PACB) today announced financial results for its fourth quarter and year ended December 31, 2017.

As quoted in the press release:

Gross profit for the year ended December 31, 2017 was $34.7 million, resulting in a gross margin of 37%. Gross profit for the year ended December 31, 2016 was $44.2 million, resulting in a gross margin of 49%. This included $12.1 million of contractual revenue at a 100% gross margin.

Click here to read the full press release.